Lymphocyte cytosolic protein 2 is a novel prognostic marker in lung adenocarcinoma
Objective Lymphocyte cytosolic protein 2 (LCP2) is often ectopically expressed in various human tumors. However, the clinical significance and role of LCP2 in lung adenocarcinoma (LUAD) remain unclear. This study explored the prognostic significance of LCP2 in LUAD patients. Methods LCP2 expression...
Saved in:
Main Authors: | Yishan Huo, Kainan Zhang, Songtao Han, Yangchun Feng, Yongxing Bao |
---|---|
Format: | article |
Language: | EN |
Published: |
SAGE Publishing
2021
|
Subjects: | |
Online Access: | https://doaj.org/article/aa5f3f99e38743f5b809e213ecae1d1a |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Zc3h12d, a Novel of Hypomethylated and Immune-Related for Prognostic Marker of Lung Adenocarcinoma
by: Yang B, et al.
Published: (2021) -
Clinicopathological and prognostic implications of ALK rearrangement in patients with completely surgically resected lung adenocarcinoma
by: Huan Zhang, et al.
Published: (2021) -
A novel prognostic signature of immune-related lncRNA pairs in lung adenocarcinoma
by: Yang Liu, et al.
Published: (2021) -
Diagnostic and prognostic potential of the oral and gut microbiome for lung adenocarcinoma
by: Mi Young Lim, et al.
Published: (2021) -
GPI Is a Prognostic Biomarker and Correlates With Immune Infiltrates in Lung Adenocarcinoma
by: Jiahui Han, et al.
Published: (2021)